This inventor holds 1 USPTO granted patent. Top assignee: Sankyo Company, Limited. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Koichi Iwasaki: Innovator in Hyperuricemia Treatment
Introduction
Koichi Iwasaki is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of medicine, particularly in the treatment and prevention of hyperuricemia. His innovative approach has the potential to impact the lives of many individuals suffering from related conditions.
Latest Patents
Iwasaki holds a patent for a method aimed at treating and preventing hyperuricemia. This patent highlights the use of insulin sensitivity enhancers, such as troglitazone, which can effectively treat or prevent hyperuricemia. The implications of this invention extend to the therapy or prophylaxis of diseases such as gout, urinary calculus, hyperuricemic nephropathy, and Lesch-Nyhan syndrome.
Career Highlights
Koichi Iwasaki is associated with Sankyo Company, Limited, where he has been able to apply his expertise in developing innovative medical solutions. His work has garnered attention for its potential to improve patient outcomes in the treatment of hyperuricemia.
Collaborations
Iwasaki has collaborated with notable colleagues, including Toshihiko Fujiwara and Hiroyoshi Horikoshi. These partnerships have contributed to the advancement of research and development in the field of hyperuricemia treatment.
Conclusion
Koichi Iwasaki's contributions to the treatment of hyperuricemia through his innovative patent demonstrate his commitment to improving healthcare. His work continues to inspire advancements in medical research and therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile